MIFH
IHE icon

Migdal Insurance & Financial Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,605
Closed -$552K – 571
2017
Q3 		$552K Buy
+10,605
New +$544K 0.01% 212

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IHE Position: Q4 2017 in Review

Migdal Insurance & Financial Holdings sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2017, closing a stake of 10,605 shares — an estimated $552K sold.

Migdal Insurance & Financial Holdings first reported a position in IHE in Q3 2017 and held it in 1 quarter. The position peaked at $552K in Q3 2017. 108 funds tracked by Wall St. Rank hold IHE as of Q4 2017.

  • Migdal Insurance & Financial Holdings reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 10,605 iShares US Pharmaceuticals ETF shares in Q4 2017, an estimated $552K.
  • Migdal Insurance & Financial Holdings first reported a position in iShares US Pharmaceuticals ETF in Q3 2017 and held it in 1 quarter.
  • Migdal Insurance & Financial Holdings's iShares US Pharmaceuticals ETF position peaked at $552K in Q3 2017.
  • 108 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2017.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2017, filed 6 Feb 2018.